Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
ICU Medical Inc (ICUI)  
$112.17 3.83 (3.54%) as of 4:30 Fri 6/7


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 23,910,000
Market Cap: 2.68(B)
Last Volume: 270,299 Avg Vol: 187,424
52 Week Range: $81.08 - $194.07
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ COMPOSITE
    S&P SMALLCAP 600     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  789
Guru Rank Value     : 1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   ICU Medical is an infusion therapy company. Co. has four product lines: Infusion Consumables, which include Clave™ needlefree products, SwabCap and SwabTip disinfecting caps, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters and Tego™ hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs; Infusion Systems, which provide infusion pumps, dedicated IV sets, software and other services; IV Solutions, which provide a supply of IV solutions, irrigation and nutritionals; and Critical Care, which helps clinicians get real-time access to patients' hemodynamic and cardiac status with a portfolio of monitoring systems and sensors and catheters.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 28,542 1,746,822 1,815,401 1,818,359
Total Sell Value $2,942,495 $185,216,328 $197,313,260 $197,870,049
Total People Sold 5 8 9 9
Total Sell Transactions 8 15 19 24
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 1485
  Page 2 of 60  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lopez George A Director   –       •      –    2024-03-11 4 S $104.22 $196,968 D/D (1,890) 317,753 -5%     
   Lopez George A Director   –       •      –    2024-03-08 4 S $105.94 $1,628,454 D/D (15,372) 319,643 -4%     
   Jain Vivek Chairman and CEO   •       •      –    2024-03-08 4 D $104.52 $622,208 D/D (5,953) 102,393     -
   Jain Vivek Chairman and CEO   •       •      –    2024-03-08 4 OE $0.00 $0 D/D 10,856 106,962     -
   Woolson Daniel VP, GM-Infusion Capital   •       –      –    2024-03-08 4 D $104.52 $93,441 D/D (894) 14,771     -
   Woolson Daniel VP, GM-Infusion Capital   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 2,020 15,665     -
   Sanzone Virginia Ruth VP, General Counsel   •       –      –    2024-03-08 4 D $104.52 $130,232 D/D (1,246) 5,798     -
   Sanzone Virginia Ruth VP, General Counsel   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 2,273 7,044     -
   Sanzone Virginia Ruth VP, General Counsel   •       –      –    2024-03-08 4 S $104.57 $345,088 D/D (3,300) 4,771 -4%     
   Bonnell Brian Michael Chief Financial Officer   •       –      –    2024-03-08 4 D $104.52 $544,549 D/D (5,210) 23,487     -
   Bonnell Brian Michael Chief Financial Officer   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 9,499 27,485     -
   Voigtlander Christian B. Chief Operating Officer   •       –      –    2024-03-08 4 D $104.52 $544,549 D/D (5,210) 11,072     -
   Voigtlander Christian B. Chief Operating Officer   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 9,499 15,070     -
   Sousa Ben Chief Information Officer   •       –      –    2024-03-08 4 D $104.52 $25,085 D/D (240) 2,483     -
   Sousa Ben Chief Information Officer   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 674 2,723     -
   Lopez George A Director   –       •      –    2024-03-07 4 S $105.77 $2,004,708 D/D (18,954) 335,015 -3%     
   Jain Vivek Chairman and CEO   •       •      –    2024-03-07 4 D $105.39 $1,301,777 D/D (12,352) 97,490     -
   Jain Vivek Chairman and CEO   •       •      –    2024-03-07 4 OE $0.00 $0 D/D 22,524 108,078     -
   Woolson Daniel VP, GM-Infusion Capital   •       –      –    2024-03-07 4 D $105.39 $315,116 D/D (2,990) 13,645     -
   Woolson Daniel VP, GM-Infusion Capital   •       –      –    2024-03-07 4 OE $0.00 $0 D/D 6,758 16,209     -
   Sanzone Virginia Ruth VP, General Counsel   •       –      –    2024-03-07 4 D $105.39 $433,785 D/D (4,116) 8,071     -
   Sanzone Virginia Ruth VP, General Counsel   •       –      –    2024-03-07 4 OE $0.00 $0 D/D 7,509 11,600     -
   Bonnell Brian Michael Chief Financial Officer   •       –      –    2024-03-07 4 D $105.39 $867,781 D/D (8,234) 19,198     -
   Bonnell Brian Michael Chief Financial Officer   •       –      –    2024-03-07 4 OE $0.00 $0 D/D 15,017 26,257     -
   Voigtlander Christian B. Chief Operating Officer   •       –      –    2024-03-07 4 D $105.39 $867,781 D/D (8,234) 6,783     -
  1485 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 60
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us